Article

Microwave treatment may be in the future of corneal refractive surgery

San Francisco-Treatment of the cornea using a novel microwave device is being investigated as a new approach for performing corneal refractive surgery without damaging the epithelium, removing tissue, or compromising structural integrity, said John Marshall, PhD.

San Francisco-Treatment of the cornea using a novel microwave device is being investigated as a new approach for performing corneal refractive surgery without damaging the epithelium, removing tissue, or compromising structural integrity, said John Marshall, PhD.

Based on the findings from biomechanical modeling studies, Dr. Marshall and colleagues at King’s College, London, hypothesized that by targeting a small circle of stromal collagen fibrils superficially and centrally, it would be possible to flatten the corneal curvature, whereas deeper treatment to modify the collagen structure in a more peripheral ring could induce steepening to correct hyperopia.

The investigational microwave system induces these changes by creating a heating effect that results in collagen shrinkage and subsequently alteration of corneal curvature. The microwaves flow between two annular electrodes. Control of the depth of the heating within the stroma is achieved by adjusting the microwave field intensity and cooling period.

In vitro studies have been performed in animal and human donor eyes. Histopathologic examination demonstrates alterations in the collagen fibrils and in the local geometry of the lamellae. The first clinical treatment was performed by Omer Faruk Yilmaz, MD, in Istanbul, Turkey, March 24.

Reminding the audience that he is “an excimer laser person”-Dr. Marshall holds the patent that led to the establishment of the first FDA approved excimer laser for refractive surgery-he also noted that as a good scientist, he is committed to expose established systems to ongoing investigation.

Referencing a quote from Winston Churchill who described a fanatic as someone who can’t change his mind and won’t change the subject, Dr. Marshall concluded by stating, “I’m always changing my mind, and I hope I am changing the subject from lasers to microwaves.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.